Altasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage
Altasciences Wins 2025 CDMO Leadership Award for Small Molecule Dosage Altasciences, a prominent contract development and manufacturing organization (CDMO), has once again been recognized for its excellence in the pharmaceutical…
Cancer ADC Market to Grow $40B by 2030 – 2024 Report
Global Cancer Antibody Drug Conjugates Market Report 2024: Industry Growth, Drug Approvals, and Market Expansion The latest report, “Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales &…
Xeris Announces Board Changes
Xeris Announces Board Changes Xeris Biopharma Holdings, Inc., a growth-oriented biopharmaceutical company dedicated to enhancing patient care through the development and commercialization of innovative therapies, has announced significant changes to…
Vertex Secures UK MHRA Approval for ALYFTREK®, a Next-Gen CFTR Modulator
Vertex Pharmaceuticals Secures UK MHRA Approval for ALYFTREK®, a Next-Generation CFTR Modulator for Cystic Fibrosis Vertex Pharmaceuticals announced today that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency…
Pharma 4.0 Report 2025: Market to Exceed $40B by 2030
Pharma 4.0 Market Report 2025: Projected Growth and Technological Advancements The “Pharma 4.0 – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering, providing an extensive analysis of the…
Merck’s SC Pembrolizumab Shows Noninferior PK to IV KEYTRUDA in Trial
Merck’s SC Pembrolizumab Shows Noninferior PK to IV KEYTRUDA in Trial Merck, known as MSD outside of the United States and Canada, has presented the first data from the pivotal…
Novotech Report Highlights Surge in siRNA Research with 150+ Clinical Trials (2020-2024)
Novotech Report Highlights Surge in siRNA Research with 150+ Clinical Trials (2020-2024) Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its latest preclinical…
Equillium Announces Q4 & Full-Year 2024 Results, Corporate & Clinical Updates
Equillium Announces Q4 & Full-Year 2024 Results, Corporate & Clinical Updates Equillium, Inc., a clinical-stage biotechnology company specializing in immunobiology, has reported its financial results for the fourth quarter and…
Kardigan Acquires Prolaio to Build Innovative Heart Health Platform
Kardigan Acquires Prolaio to Build Innovative Heart Health Platform Kardigan, a heart health company focused on modernizing cardiovascular (CV) drug development, has announced its acquisition of Prolaio, a clinical intelligence…
Havah Therapeutics Files Patent for HAV-088 in Breast Cancer Treatment
Havah Therapeutics Files Patent for HAV-088 in Breast Cancer Treatment Havah Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative therapies for the prevention and treatment of breast cancer, has…
Japan Approves TIVDAK® for Advanced Cervical Cancer Treatment
Japan Approves TIVDAK® for Advanced Cervical Cancer Treatment Genmab A/S has announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has approved TIVDAK® (tisotumab vedotin) for the treatment…
Preclinical Intranasal COVID-19 Vaccine Shows Lasting Immunity & Broad Protection
Blue Lake Biotechnology’s Intranasal COVID-19 Vaccine Candidate Demonstrates Long-Lasting Immunity and Broad Protection Blue Lake Biotechnology, Inc., a clinical-stage biotechnology company specializing in intranasal vaccine development, along with its affiliate…